SCHEMBL3846924

SCHEMBL3846924

COCc1cccc(N2CCN(c3ncnc4ccc(-c5cn[nH]c5)cc34)CC2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.51
CYP1A2 P05177 13/20 0.49
CYP3A4 P08684 13/20 0.49
CLK4 Q9HAZ1 10/20 0.49
ALDH1A1 P00352 9/20 0.49
USP2 O75604 7/20 0.49
HIF1A Q16665 7/20 0.49
CYP2C19 P33261 6/20 0.49
CYP2D6 P10635 6/20 0.49
LMNA P02545 6/20 0.49
MAPK1 P28482 5/20 0.49
HSD17B10 Q99714 1/20 0.48
MEN1 O00255 7/20 0.46
KMT2A Q03164 7/20 0.46
TSHR P16473 3/20 0.46
ALOX15 P16050 1/20 0.46
KDM1A O60341 1/20 0.45
KDM4E B2RXH2 3/20 0.44
HPGD P15428 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3850378 0.86 AKT1 (0.51) AKT1CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL4714577 0.85 CYP1A2 (0.51) AKT1CYP1A2CYP3A4CLK4ALDH1A1
Hydrochloric Acid SCHEMBL3849363 0.85 CYP1A2 (0.50) AKT1CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL5853346 0.84 AKT1 (0.54) AKT1CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL3855266 0.84 AKT1 (0.59) AKT1CYP1A2CYP3A4CLK4ALDH1A1
Hydrochloric Acid SCHEMBL3851639 0.83 ACHE (0.54) AKT1CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL13874403 0.83 CYP1A2 (0.49) AKT1CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL4716295 0.81 CYP1A2 (0.50) AKT1CYP1A2CYP3A4CLK4ALDH1A1
Hydrochloric Acid SCHEMBL3846099 0.80 AKT1 (0.48) AKT1CYP1A2CYP3A4CLK4ALDH1A1
Hydrochloric Acid SCHEMBL3853817 0.80 AKT1 (0.48) AKT1CYP1A2CYP3A4CLK4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed